Table 1 Patient demographics and clinical history
From: Qualitative and quantitative validation of the FACIT-fatigue scale in iron deficiency anemia
Baseline characteristics | Psychometric Validation Sample | Qualitative Content Validation Sample | |
|---|---|---|---|
Ferumoxytol (n = 608) | Placebo (n = 200) | ||
Age, years, mean (± SD) | 44.8 (±13.82) | 46.0 (±13.58) | 41.7 (±11.3) |
Female, n (%) | 542 (89.1) | 178 (89.0) | 14 (93.3) |
Race, n (%) | |||
Asian | 98 (16.1) | 32 (16.0) | - |
Black/African American | 152 (25.0) | 50 (25.0) | 11 (73.3) |
White | 340 (55.9) | 111 (55.5) | 4 (26.7) |
Other/Multiracial | 18 (3.0) | 7 (3.5) | - |
Hgb g/dL, mean (± SD) | 8.9 (±0.89) | 8.8 (±0.89) | - |
TSAT, mean (± SD) | 7.0 (12.9) | 5.4 (4.9) | - |
Underlying condition, n (%) | |||
AUB | 260 (42.8) | 84 (42.0) | 11 (73.3) |
Cancer | 29 (4.8) | 10 (5.0) | - |
GI disorders | 173 (28.5) | 58 (29.0) | 1 (6.7) |
Postpartum anemia | 4 (0.7) | 0 (0.0) | 2 (13.3) |
Other a | 142 (23.4) | 48 (24.0) | 1 (6.7) |
FACIT-fatigue, mean (± SD) | 24.1 (11.8) | 24.7 (11.3) | - |